On May 27, 2025, we had the pleasure of hosting the 3rd Consortium Meeting of the TRANS2DCHEM project in Prague. This full-day event brought together representatives from our esteemed partner institutions – Czech Advanced Technology and Research Institute (CATRIN), Itelcond, and Bar-Ilan Institute for Nanotechnology and Advanced Materials (BINA), Bar-Ilan University – for a series of productive discussions focused on project progress, challenges, and strategic alignment for the months ahead.
🔬 Technical Focus
The central theme of the meeting revolved around prototype performance, optimization strategies, and scaling-up processes. Particular attention was given to the transition from pouch to wound cell formats and the evaluation of key performance indicators – essential steps on our path toward delivering high-performance supercapacitor technology.
📊 Market and Commercialization Strategy
In addition to technical milestones, partners engaged in a detailed exchange on market intelligence and customer feedback, both of which are critical for refining our product–market fit and strengthening the route to successful commercialization.
🤝 Spotlight on ATOMIVER
We were especially honored to welcome Andrew Hladký, CEO of ATOMIVER, the official spin-out company of the TRANS2DCHEM project. Andrew presented the latest developments and strategic roadmap of ATOMIVER, including steps toward large-scale production of SC-GN3 – our breakthrough nitrogen-superdoped graphene material.
